Skip to main content

Loading market data...

ALHC

Alignment Healthcare, Inc.

NASDAQ • United states

$8.40

+$0.12

(+1.45%)

Source: Yahoo Finance · Quote time Oct 19, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Alignment Healthcare, Inc. (ALHC)

Unavailable

Quotes may be delayed

$1.74B

Market Cap

3,581,784

Volume

42.8

P/E Ratio

Unavailable

Div Yield

Alignment Healthcare, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 1100 W. TOWN AND COUNTRY ROAD, ORANGE, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

9 Oct 2026

Alignment Healthcare, Inc. reported Regulation FD disclosure

Alignment Healthcare, Inc. filed an 8-K covering Regulation FD disclosure.

5 Oct 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alignment Healthcare, Inc..

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alignment Healthcare, Inc..

31 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Alignment Healthcare, Inc..

31 Jul 2026

Alignment Healthcare, Inc. filed Form 10-Q

Alignment Healthcare, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$693.45M

Total assets (USD)$1.28B

Total liabilities (USD)$1.01B

Shareholders' equity (USD)$265.13M

Long-term debt (USD)$324.06M

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.34B	$42.10M	$36.56M	$0.17	10-Q · 30 Jul 2026
Q1 2026	$1.24B	$15.50M	$11.42M	$0.05	10-Q · 30 Apr 2026
Q4 2025	$1.01B	−$10.28M	−$11.01M	Unavailable	10-K · 27 Feb 2026
Q3 2025	$993.70M	$7.68M	$3.73M	$0.02	10-Q · 30 Oct 2025
Q2 2025	$1.02B	$22.75M	$15.67M	$0.07	10-Q · 30 Jul 2025
Q1 2025	$926.93M	−$5.39M	−$9.11M	−$0.05	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $13.25

57.7% upside potential

📈

Strong Buy

Unavailable

👍

Buy

6

⏸️

Hold

4

📉

Sell

0

10 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 12:48 UTC Targets range 9.00–25.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

6

Oct 2026

Kim Hyong

Chief Medical Officer

Open-market sale

$8.30 per share

32,479 shares

17

Sep 2026

KONOWIECKI JOSEPH S

Director, EVP, Corporate Affairs

Open-market sale

$8.61 per share

23,511 shares

14

Sep 2026

KAO JOHN E

Director, Chief Executive Officer

Open-market sale

$13.00 per share

27,400 shares

11

Sep 2026

Maroney Dawn Christine

President

Open-market sale

$12.68 per share

122,707 shares

11

Sep 2026

KAO JOHN E

Director, Chief Executive Officer

Open-market sale

$12.68 per share

385,270 shares

10

Sep 2026

KAO JOHN E

Director, Chief Executive Officer

Open-market sale

$12.96 per share

172,600 shares

14

Aug 2026

Maroney Dawn Christine

President

Open-market sale

$14.00 per share

5,000 shares

10

Aug 2026

KAO JOHN E

Director, Chief Executive Officer

Open-market sale

$13.88 per share

298,000 shares

15

Jul 2026

Maroney Dawn Christine

President

Option exercise

$9.06 per share

152,068 shares

15

Jul 2026

Maroney Dawn Christine

President

Open-market sale

$20.83 per share

177,068 shares

Top Shareholders

Blackrock, Inc.

19,342,956 shares

37.426% change

6/30/2026

Wellington Management Group Llp

18,780,363 shares

9.834% change

6/30/2026

Vanguard Group Inc

15,492,802 shares

10.912% change

12/31/2025

Fmr Llc

13,924,329 shares

-12.382% change

6/30/2026

T. Rowe Price Investment Management, Inc.

13,119,557 shares

-0.214% change

6/30/2026

Vanguard Portfolio Management Llc

11,672,259 shares

20.208% change

6/30/2026

Invesco Ltd.

10,365,640 shares

48.078% change

6/30/2026

Bank Of America Corp /De/

9,346,742 shares

190.663% change

6/30/2026

Vanguard Capital Management Llc

8,144,247 shares

2.139% change

6/30/2026

William Blair Investment Management, Llc

7,761,403 shares

48.839% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 12:48 UTC· 1 day ago

Research coverage and investment tools

Alignment Healthcare, Inc. (ALHC) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical Specialities). Its last price was US$8.40 on 19 Oct 2026. That is 13% of the way from its 52-week low of US$6.01 to its 52-week high of US$25.12. Its market capitalisation was US$1.74 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.34B	$42.10M	$36.56M	$0.17	—	3.2%	−$27.46M	10-Q · 30 Jul 2026 (opens in a new tab)
Q1 2026	$1.24B	$15.50M	$11.42M	$0.05	—	1.3%	$121.32M	10-Q · 30 Apr 2026 (opens in a new tab)
Q4 2025	$1.01B	−$10.28M	−$11.01M	Unavailable	—	-1.0%	−$55.40M	10-K · 27 Feb 2026 (opens in a new tab)
Q3 2025	$993.70M	$7.68M	$3.73M	$0.02	—	0.8%	$139.06M	10-Q · 30 Oct 2025 (opens in a new tab)
Q2 2025	$1.02B	$22.75M	$15.67M	$0.07	—	2.2%	$21.13M	10-Q · 30 Jul 2025 (opens in a new tab)
Q1 2025	$926.93M	−$5.39M	−$9.11M	−$0.05	—	-0.6%	$8.36M	10-Q · 1 May 2025 (opens in a new tab)

Cash and equivalents: $693.45M
Total assets: $1.28B
Total liabilities: $1.01B
Shareholders' equity: $265.13M
Long-term debt: $324.06M
Debt due within a year: $0

8-K · 9 Oct 2026

Alignment Healthcare, Inc. reported Regulation FD disclosure (opens in a new tab)

Alignment Healthcare, Inc. filed an 8-K covering Regulation FD disclosure.
SCHEDULE 13G/A · 5 Oct 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Alignment Healthcare, Inc..
SCHEDULE 13G · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Alignment Healthcare, Inc..
SCHEDULE 13G · 31 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Alignment Healthcare, Inc..
10-Q · 31 Jul 2026

Alignment Healthcare, Inc. filed Form 10-Q (opens in a new tab)

Alignment Healthcare, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Kim Hyong Chief Medical Officer	6 Oct 2026	Open-market sale (S)	−32,479	$8.30	Form 4 (opens in a new tab)
KONOWIECKI JOSEPH S Director, EVP, Corporate Affairs	17 Sep 2026	Open-market sale (S)	−23,511	$8.61	Form 4 (opens in a new tab)
KAO JOHN E Director, Chief Executive Officer	14 Sep 2026	Open-market sale (S)	−27,400	$13.00	Form 4 (opens in a new tab)
Maroney Dawn Christine President	11 Sep 2026	Open-market sale (S)	−122,707	$12.68	Form 4 (opens in a new tab)
KAO JOHN E Director, Chief Executive Officer	11 Sep 2026	Open-market sale (S)	−385,270	$12.68	Form 4 (opens in a new tab)
KAO JOHN E Director, Chief Executive Officer	10 Sep 2026	Open-market sale (S)	−172,600	$12.96	Form 4 (opens in a new tab)
Maroney Dawn Christine President	14 Aug 2026	Open-market sale (S)	−5,000	$14.00	Form 4 (opens in a new tab)
KAO JOHN E Director, Chief Executive Officer	10 Aug 2026	Open-market sale (S)	−298,000	$13.88	Form 4 (opens in a new tab)
Maroney Dawn Christine President	15 Jul 2026	Option exercise (M)	+152,068	$9.06	Form 4 (opens in a new tab)
Maroney Dawn Christine President	15 Jul 2026	Open-market sale (S)	−177,068	$20.83	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	19,342,956	37.426%
Wellington Management Group Llp	6/30/2026	18,780,363	9.834%
Vanguard Group Inc	12/31/2025	15,492,802	10.912%
Fmr Llc	6/30/2026	13,924,329	-12.382%
T. Rowe Price Investment Management, Inc.	6/30/2026	13,119,557	-0.214%
Vanguard Portfolio Management Llc	6/30/2026	11,672,259	20.208%
Invesco Ltd.	6/30/2026	10,365,640	48.078%
Bank Of America Corp /De/	6/30/2026	9,346,742	190.663%
Vanguard Capital Management Llc	6/30/2026	8,144,247	2.139%
William Blair Investment Management, Llc	6/30/2026	7,761,403	48.839%

Previous close: 8.28 USD
Day range: 8.22 – 8.54 USD
52-week range: 6.01 – 25.12 USD
Volume: 3,581,784
Market cap: $1.74B
Average volume: 8,585,590
P/E ratio: 42.8
EPS (FY 2025, diluted): 0.00 USD
Shares outstanding: 207.44M
Beta (5Y monthly): 1.03

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 19 Oct 2026, 20:00 UTC· 2 days ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:06 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ALHC yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.